ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Shining a Spotlight on Immunotherapy – ScienceBlog.com (blog)

ScienceBlog.com (blog)Shining a Spotlight on ImmunotherapyScienceBlog.com (blog)The American Society of Clinical Oncologists (ASCO) has declared immunotherapy the Clinical Advance Of The Year for the second year running – a sentiment that is very much … Continue reading

2018-01-25 Michael Zand NEWS

MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy – Markets Insider

MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene TherapyMarkets InsiderSAN FRANCISCO, Jan. 25, 2018 /PRNewswire/ — MultiVir Inc. presented updated data at the annual ASCO-SITC Clinical Immuno-Oncology Symposium dem… Continue reading

2018-01-25 Michael Zand NEWS

How Does Immunotherapy Help People With Milk Protein Allergies? – Forbes

ForbesHow Does Immunotherapy Help People With Milk Protein Allergies?ForbesSub-lingual immunotherapy (SLIT) also uses your allergen to treat your allergy (with drops under the tongue instead of ingestion), but I am not sure if the protein drops that th… Continue reading

2018-01-25 Michael Zand NEWS

John Theurer Cancer Center First NJ Site Certified to offer CAR-T Cell Cancer Therapy – PR Newswire (press release)

John Theurer Cancer Center First NJ Site Certified to offer CAR-T Cell Cancer TherapyPR Newswire (press release)"John Theurer Cancer Center has been involved in CAR-T cell therapy research for nearly a decade," said André Goy, M.D., chairman … Continue reading

2018-01-25 Michael Zand NEWS

Novartis Pays Spark $105M Up Front for Gene Therapy Rights Outside US – Xconomy

XconomyNovartis Pays Spark $105M Up Front for Gene Therapy Rights Outside USXconomySpark Therapeutics is licensing to Novartis the rights to its gene therapy outside of the U.S., a deal that puts the treatment for a rare, inherited form of blindness in… Continue reading

2018-01-25 Michael Zand NEWS

Doomsday Clock Is Set at 2 Minutes to Midnight, Closest Since 1950s – New York Times

Continue reading

2018-01-25 Michael Zand NEWS

ASU researcher earns recognition for regenerative engineering method using synthetic biology – Arizona State University

Arizona State UniversityASU researcher earns recognition for regenerative engineering method using synthetic biologyArizona State UniversityStem cells possess great potential for the study and treatment of disease. Scientists can use them to grow lab-c… Continue reading

2018-01-25 Michael Zand NEWS

Burlington Native Researching Immunotherapy to Treat Cancer – Tri States Public Radio


New York Times

Doomsday Clock Is Set at 2 Minutes to Midnight, Closest Since 1950s
New York Times
The Doomsday Clock, a potent symbol of scientific concerns about humanity’s possible annihilation, was advanced by 30 seconds on Thursday, to 2 minutes to midnight, the Bulletin of the Atomic Scientists announced in Washington. The last time the clock …
Bulletin of the Atomic ScientistsBulletin of the Atomic Scientists
Why the Doomsday Clock is an idiotic indicator the world’s media should ignoreNational Post

all 202 news articles »

Continue reading

2018-01-25 Michael Zand NEWS
  • 1
  • …
  • 614
  • 615
  • 616
  • 617
  • 618
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Tri States Public Radio

Burlington Native Researching Immunotherapy to Treat Cancer
Tri States Public Radio
Now Rogers is a postdoctoral fellow at the University of Iowa where she does research into immunotherapy for cancer patients. She said the treatment uses a patient’s immune system to fight cancer. “I think by the time you have a tumor, your immune …